Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,414 | -10,947 | -7,686 | -2,568 | -11,221 |
| Depreciation Amortization | 2,648 | 1,946 | 1,259 | 621 | 2,238 |
| Income taxes - deferred | N/A | -2,190 | N/A | N/A | N/A |
| Accounts receivable | 4,113 | 4,069 | 4,088 | 2,425 | -4,113 |
| Accounts payable and accrued liabilities | -514 | -1,679 | -1,026 | -1,409 | -334 |
| Other Working Capital | 4,685 | 4,223 | 3,994 | 2,820 | -68,684 |
| Other Operating Activity | 75,927 | 75,782 | 73,977 | -80 | 16,965 |
| Operating Cash Flow | $69,445 | $71,204 | $74,606 | $1,809 | $-65,149 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,525 | -3,049 | -2,349 | -637 | -3,727 |
| Investing Cash Flow | $-3,525 | $-3,049 | $-2,349 | $-637 | $-3,727 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,995 | 7,962 | 4,998 | 1,022 | -409,724 |
| Dividend Paid | -75,003 | -75,003 | N/A | N/A | N/A |
| Financing Cash Flow | $-67,008 | $-67,041 | $4,998 | $1,022 | $-409,724 |
| Exchange Rate Effect | 705 | 397 | 637 | 319 | 1,372 |
| Beginning Cash Position | 237,366 | 237,366 | 237,366 | 237,366 | 714,594 |
| End Cash Position | 236,983 | 238,877 | 315,258 | 239,879 | 237,366 |
| Net Cash Flow | $-383 | $1,511 | $77,892 | $2,513 | $-477,228 |
| Free Cash Flow | |||||
| Operating Cash Flow | 69,445 | 71,204 | 74,606 | 1,809 | -65,149 |
| Capital Expenditure | -3,525 | -3,049 | -2,349 | -637 | -3,727 |
| Free Cash Flow | 65,920 | 68,155 | 72,257 | 1,172 | -68,876 |